Braidwell is a fund manager in Stamford with $4.62 bn assets under management.
Company profile
Website
Employees
Incorporated
Fiscal year end
SEC CIK
IRS number
861247398
SEC advisor number
801-122966
FINRA CRD number
316988
AUM ?
$4.90 bn
(as of 28 Mar 24)
Accounts
8
(as of 28 Mar 24)
Employees
38
(20 investment advisory or research)
Ownership
Fund structure | AUM | Fund type |
---|---|---|
Braidwell LP | $4.62 bn | |
Braidwell Companion CMV Master Fund LP | Hedge Fund | |
Braidwell Companion CMV (Us) LP - 2023-1 Series | $65.66 mm | Hedge Fund |
Braidwell Companion CMV LP | $66.50 mm | Hedge Fund |
Braidwell Companion CMV Transaction Master Fund LP | Hedge Fund | |
Braidwell Companion CMV (Us) LP | ||
Braidwell Companion CMV LP | ||
Braidwell Partners Master Fund LP | $3.49 bn | Hedge Fund |
Braidwell Partners (Us) LP | $1.11 bn | Hedge Fund |
Braidwell Partners LP | $2.38 bn | Hedge Fund |
Braidwell Partners Transaction Master Fund LP | Hedge Fund | |
Braidwell Partners (Us) LP | ||
Braidwell Partners LP |
Latest filings (excl ownership)
No filings
Latest ownership filings
13F-HR
Quarterly holdings report by institutional manager
14 Feb 24
SC 13G/A
Deciphera Pharmaceuticals, Inc.
14 Feb 24
SC 13G/A
Crinetics Pharmaceuticals, Inc.
14 Feb 24
SC 13G/A
DBV Technologies S.A.
14 Feb 24
13F-HR
Quarterly holdings report by institutional manager
14 Nov 23
13F-HR
Quarterly holdings report by institutional manager
14 Aug 23
13F-HR
Quarterly holdings report by institutional manager
15 May 23
13F-HR
Quarterly holdings report by institutional manager
14 Feb 23
SC 13G
DBV Technologies S.A.
14 Feb 23
SC 13G
Crinetics Pharmaceuticals, Inc.
14 Feb 23